Table 5 Association between LV diastolic dysfunction and circulating lncRNAs in patients with well-controlled type 2 diabetes.

	OR (95% IC)	P-value
Univariate analysis
LIPCAR	1.047 (1.008, 1.087)	0.017*
uc004cos.4	1.033 (1.006, 1.062)	0.018*
uc004cov.4	1.172 (1.027, 1.337)	0.018*
uc004coz.1	1.040 (1.004, 1.077)	0.027*
uc011mfi.2	1.107 (1.019, 1.203)	0.017*
uc022bqw.1	1.043 (1.006, 1.082)	0.022*
uc022bqu.1	1.049 (1.008, 1.093)	0.020*
H19	1.959 (0.469, 9.178)	0.356
HOTAIR	1.067 (0.904, 1.259)	0.446
MIAT	0.890 (0.170, 4.666)	0.890
SENCR	1.673 (0.119, 3.545)	0.703
Multivariate analysis
Model 1
LIPCAR	1.053 (1.007, 1.101)	0.023*
Age	1.090 (0.957, 1.240)	0.195
BMI	1.171 (0.938, 1.462)	0.163
Model 2
Association between LV diastolic dysfunction and circulating LIPCAR for model 1 and each of following variables:
Plasma fasting glucose	1.058 (1.008, 1.111)	0.022*
Plasma fasting insulin	1.046 (1.002, 1.091)	0.040*
Time since diagnosis of diabetes	1.048 (1.003, 1.094)	0.034*
Myocardial Steatosis	1.054 (1.007, 1.103)	0.024*
HDL cholesterol	1.049 (1.005, 1.095)	0.030*
SBP	1.053 (1.007, 1.101)	0.022*
DBP	1.052 (1.006, 1.100)	0.025*
Heart rate	1.056 (1.008, 1.106)	0.021*
us-CRP	1.045 (1.001, 1.091)	0.044*
NT-proBNP	1.064 (1.013, 1.118)	0.013*

Quick links

Search